Celldex Therapeutics, Inc. (CLDX) Earnings
|
Expand Research on CLDX
| Next EPS Date | 11/11/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +0.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +7.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/11/26  |
Q326 | N/A | -$1.07 | N/A | N/A | $801.58K | N/A | N/A | N/A | ||
| 8/6/26 | Q226 | -$0.94 | -$1.06 | +$0.12 | $22K | $802.64K | N/A |  | | Details | |
| 5/7/26 |
Q126 | -$1.18 | -$1.19 | +$0.01 | $15K | $874.9K | N/A | | | Details | |
| 5/4/26 |
Q126 | N/A | -$1.19 | N/A | N/A | $874.9K | N/A | N/A | N/A | ||
| 5/1/26 |
Q126 | N/A | -$1.19 | N/A | N/A | $874.9K | N/A | N/A | N/A | ||
| 4/30/26 |
Q126 | N/A | -$1.19 | N/A | N/A | $874.9K | N/A | N/A | N/A | ||
| 3/2/26 |
Q425 | N/A | -$1.01 | N/A | N/A | $1.39M | N/A | N/A | N/A | ||
| 11/10/25 | Q325 | -$1.01 | -$0.90 | -$0.11 | N/A | $1.08M | N/A | | | Details |
